Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. QIPT
stocks logo

QIPT

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
63.68M
+3.95%
-0.020
-71.43%
76.46M
+24.49%
-0.030
-0%
76.81M
+33.73%
-0.070
-0%
Estimates Revision
The market is revising No Change the revenue expectations for Quipt Home Medical Corp. (QIPT) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -4.63%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-4.63%
In Past 3 Month
Wall Street analysts forecast QIPT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for QIPT is 3.16 USD with a low forecast of 2.31 USD and a high forecast of 4.02 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast QIPT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for QIPT is 3.16 USD with a low forecast of 2.31 USD and a high forecast of 4.02 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 2.470
sliders
Low
2.31
Averages
3.16
High
4.02
Current: 2.470
sliders
Low
2.31
Averages
3.16
High
4.02
Canaccord
Richard Close
Hold
maintain
2025-08-19
Reason
Canaccord
Richard Close
Price Target
2025-08-19
maintain
Hold
Reason
Canaccord analyst Richard Close raised the firm's price target on Quipt Home Medical (QIPT) to $2.30 from $1.70 and keeps a Hold rating on the shares. The firm said they demonstrated improvement in 3Q with a sequential uptick across metrics, though it remains down year over year as the company works through some headwinds such as its Humana MA (HUM) capitated contract and disposable supply contract non-renewal.
Canaccord
Richard Close
Buy
to
Hold
downgrade
$4
2025-05-14
Reason
Canaccord
Richard Close
Price Target
$4
2025-05-14
downgrade
Buy
to
Hold
Reason
Bill Sutherland
Buy
downgrade
$6 -> $4
2025-05-14
Reason
Bill Sutherland
Price Target
$6 -> $4
2025-05-14
downgrade
Buy
Reason
Benchmark analyst Bill Sutherland lowered the firm's price target on Quipt Home Medical to $4 from $6 and keeps a Buy rating on the shares after revenue missed expectations in fiscal Q2. On a positive note, Quipt continues to see no negative impact from GLP-1 medications on demand for sleep therapy set ups and supplies, like other respiratory-focused home medical equipment companies, the analyst noted.
Canaccord
Buy
to
Hold
downgrade
$4
2025-05-13
Reason
Canaccord
Price Target
$4
2025-05-13
downgrade
Buy
to
Hold
Reason
Canaccord downgraded Quipt Home Medical to Hold from Buy with a price target of $1.70, down from $4.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Quipt Home Medical Corp (QIPT.O) is -13.72, compared to its 5-year average forward P/E of 2.03. For a more detailed relative valuation and DCF analysis to assess Quipt Home Medical Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
2.03
Current PE
-13.72
Overvalued PE
128.01
Undervalued PE
-123.94

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
4.65
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
6.13
Undervalued EV/EBITDA
3.16

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.87
Current PS
0.00
Overvalued PS
1.30
Undervalued PS
0.43
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

QIPT News & Events

Events Timeline

(ET)
2025-10-22
12:28:07
Lakeview calls on Quipt board to conduct a 'genuine' evaluation of strategic alternatives
select
2025-09-10 (ET)
2025-09-10
08:47:19
Forager expresses dedication to advancing Quipt Home Medical deal
select
2025-09-03 (ET)
2025-09-03
08:39:17
Forager claims Quipt board is driven by self-interested strategies.
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.0
10-23Newsfilter
Lakeview Calls on Quipt's Board to Conduct a Genuine Evaluation of All Strategic Alternatives, Including a Sale and a Serious $3.10 All-Cash Bid.

  • Board's Mismanagement: Lakeview Investment Group criticizes Quipt Home Medical Corp.'s Board for failing to engage with credible bidders and for prioritizing its own interests over shareholder value, leading to significant value destruction.

  • Shareholder Sentiment: The Board's actions, including issuing equity-based compensation and pursuing litigation against a major shareholder, have alienated investors, who are frustrated with the lack of positive returns and transparency.

  • Bidder Proposal: A publicly disclosed bidder has made a $3.10 per share offer, which Lakeview believes undervalues the company, and they advocate for a transparent strategic review process to explore a sale at a premium.

  • Call for Change: Lakeview urges the Board to adopt a credible review process with independent advisors to rebuild trust, warning that all Board members may face removal if the current situation continues.

[object Object]
Preview
4.0
09-25NASDAQ.COM
Everything You Should Know About Quipt Home Medical (QIPT) Rating Increase to Buy

  • Quipt Home Medical Corp. Upgrade: Quipt Home Medical Corp. has received a Zacks Rank #2 (Buy) due to a significant increase in earnings estimates, indicating a positive outlook for the company's stock price.

  • Zacks Rating System: The Zacks rating system, which evaluates stocks based on earnings estimate revisions, shows that Quipt is in the top 20% of covered stocks, suggesting potential for market-beating returns in the near term.

[object Object]
Preview
8.5
09-21Yahoo Finance
Nuveen Acquires Stake in Quipt Home Medical Corp. (QIPT)

  • Investment Interest: Quipt Home Medical Corp. (NASDAQ: QIPT) has attracted investment from Nuveen LLC, which acquired 150,046 shares valued at approximately $350,000, representing nearly 0.35% ownership in the company.

  • Strategic Growth Initiatives: The company is expanding through strategic partnerships, including a $17.4 million acquisition of Hart Medical Equipment, which enhances its ownership stake and stabilizes revenue while creating opportunities for future growth.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Quipt Home Medical Corp (QIPT) stock price today?

The current price of QIPT is 2.47 USD — it has increased 2.07 % in the last trading day.

arrow icon

What is Quipt Home Medical Corp (QIPT)'s business?

Quipt Home Medical Corp. provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. The Company's expertise spans across a full spectrum of respiratory care, providing an end-to-end solution for medical providers and patients. This includes technology enabled equipment offerings and specialized care for patients with cardio and pulmonary diseases, sleep disorders, mobility challenges, and other chronic disease management. The Company's healthcare products and services include sleep apnea and pap treatment, home medical equipment, home ventilation and custom mobility solutions. It has a 60% ownership interest in Hart Medical Equipment, which maintains strategic relationships with integrated health systems and freestanding community-based hospitals, embedding the business into the hospital discharge processes of more than 19 hospitals and affiliated care facilities across its network.

arrow icon

What is the price predicton of QIPT Stock?

Wall Street analysts forecast QIPT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for QIPT is 3.16 USD with a low forecast of 2.31 USD and a high forecast of 4.02 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Quipt Home Medical Corp (QIPT)'s revenue for the last quarter?

Quipt Home Medical Corp revenue for the last quarter amounts to 58.29M USD, decreased -4.07 % YoY.

arrow icon

What is Quipt Home Medical Corp (QIPT)'s earnings per share (EPS) for the last quarter?

Quipt Home Medical Corp. EPS for the last quarter amounts to -0.07 USD, increased 75.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Quipt Home Medical Corp (QIPT)'s fundamentals?

The market is revising No Change the revenue expectations for Quipt Home Medical Corp. (QIPT) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -4.63%.
arrow icon

How many employees does Quipt Home Medical Corp (QIPT). have?

Quipt Home Medical Corp (QIPT) has 1100 emplpoyees as of December 05 2025.

arrow icon

What is Quipt Home Medical Corp (QIPT) market cap?

Today QIPT has the market capitalization of 104.70M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free